Associate Director
US Food & Drug Administration
Rajanikanth (Raj) Madabushi, PhD, has over 15 years of regulatory experience as a Pharmacometrics Reviewer and Clinical Pharmacology Team Lead in the Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS) at CDER/FDA. He currently serves as the Associate Director, Guidance and Scientific Policy in OCP and the Director of the CDER Quantitative Medicine Center of Excellence. Dr. Madabushi plays an instrumental role in FDA’s PDUFA MIDD initiatives and is the CDER Point-of-Contact for the MIDD Paired Meeting Program. Dr. Madabushi led global harmonization activities as the Rapporteur for ICH M12 Expert Working Group – Drug Interaction Studies. Dr. Madabushi received his PhD in Pharmaceutical Sciences from Birla Institute of Technology and Sciences (BITS), Pilani, India.
Disclosure information not submitted.
Symposium 16: New Perspectives on Drug Evaluation in Older Adults
Tuesday, September 10, 2024
1:30 PM – 3:00 PM ET
4 - Advancing Drug Evaluation in Older Adults: Regulatory Considerations
Tuesday, September 10, 2024
1:30 PM – 3:00 PM ET